All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Innovative Agreements Framework

Many products coming to market are poorly served by traditional negotiation approaches. This document describes innovative agreements being used in jurisdictions outside Canada. We prepared it to guide discussions with the pCPA Governing Council on the merits of jointly developing an innovative agreements framework.

Learn more|View

Canadian Drug Access Pathway

The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (732 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).

Learn more|View

Letter to The Honourable Mary Ng, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

*Cette lettre est disponible en anglais seulement.

Learn more|View


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.